Trial intelligence / Profile preview

Dexamethasone in Mucolox for Oral Lichen Planus

NCT02850601Phase 2Completed

Sponsor
Brigham and Women's Hospital
Start
Feb 2017
Primary completion
Dec 2019
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of dexamethasone in oral lichen planus (OLP), sponsored by Brigham and Women's Hospital. Started Feb 2017; status: completed.

02

Drugs

dexamethasone
03

Conditions

oral lichen planus (OLP)

Beyond the preview

Go deeper on NCT02850601.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02850601.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call